Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford secures £7.8M funding to become Cancer Research UK’s joint largest Centre for training clinical academics.

Multiplex IF image of skin biopsy © Alistair Easton

Lead by Cancer Research UK Oxford Centre co-director Mark Middleton, this funding (for 8 DPhil studentships per year) galvanises Oxford’s position as one of the world’s leading Centres for the training of clinician scientists. With the additional funding the Centre will more than double its clinical DPhil intake for 2020, and for the first time allow medical undergraduates, in addition to clinical trainees, the opportunity to commit to a career in cancer research.

The successful Oxford team that included Dr. Catherine Swales (Oxford Medical School Director of Clinical Studies), Rob Gilbert (Director Of Medical Sciences Doctoral Training Centre), Chris Pugh (Oxford University Clinical Academic Graduate School Director), Denise Best (Oxford University Clinical Academic Graduate School Associate Director) and Chris Norbury (Medical School Deputy Director Of Pre-Clinical Studies) structured Oxford’s scheme to provide researchers:

  • The opportunity to receive research training in world leading laboratory environments across both the Medical Sciences and Mathematical, Physics and Life Sciences Divisions.
  • The ability to gain a working in-depth knowledge of the fundamentals of cancer biology and cancer patient care through advanced level seminars.
  • An environment that nurtures talent and offers a post award support programme that has historically meant Oxford students are 20 times more likely than the national average to develop an independent academic career.

This vision for training the next generation of cancer researchers will be delivered through the newly launched DPhil in Cancer Science Programme, a Medical Sciences Doctoral Training Centre. This new qualification is available to both clinician and non-clinicians, will have an annual intake of between 11 and 20 students per year, bring cancer and oncology training of DPhil students at Oxford into line with other diseases and help drive improvements in cancer patient care using Oxford research expertise in the near future.

Professor Mark Middleton, Cancer Research UK Oxford Centre Co-Director, said: 'We are tremendously grateful to Cancer Research UK and their donors for the confidence they have shown in enabling us to build a new training platform that will provide cancer research leaders of the future a unique and exciting first step into the field.'

Dr Karen Noble, Cancer Research UK Head of Research Careers, said: 'Clinical researchers play an important role in helping CRUK achieve its mission of seeing 3 in 4 people survive their cancer within the next 20 years. Through the funding to Oxford, the best people will be able to train in the best labs at the time in their career that best suits them. As well as support for clinical trainees, we are excited to be funding MB-DPhil training, which will enable aspiring clinician scientists to undertake a DPhil as part of their medical degree.'

Similar stories

Young lives under pressure as global crises hits mental health and well-being – report

The well-being and mental health of young people in low - and middle - income countries have been dramatically affected by the series of crises hitting the world. As the international community continues to struggle with the impact of COVID-19, conflict and climate change, the latest report from the Young Lives project shows a long-running upward trend in young people’s well-being has been sharply reversed alongside widespread anxiety and depression. Young people are less confident about their futures for the first time in the 20-year study.

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

New tool aims to make bowel cancer treatments more effective

The Leedham Lab in Nuffield Department of Medicine (NDM) has been awarded over £2M from Cancer Research UK to develop a new tool that could help guide how bowel cancer patients are treated in the future.

Doug Higgs awarded the 2023 Genetics Society Medal

The award recognises Radcliffe Department of Medicine's Professor Higgs major contribution to our understanding of how mammalian genes are switched on and off, and using haematopoiesis as a model to understand how genes function.

First evidence drug resistant bacteria can travel from gut to lung, increasing infection risks

A new Oxford University study released during World Antimicrobial Awareness Week has significant findings on how antimicrobial resistance (AMR) arises and persists. The results, published today in Nature Communications, provide the first direct evidence of AMR bacteria migrating from a patient’s gut microbiome to the lungs, increasing the risk of deadly infections.